Active ingredientTecovirimatCat. No. P-T030-001CAS 869572-92-9Family · Pharmaceutical analytical standards
Tecovirimat
An oral antiviral against orthopoxviruses, the first of its kind approved in the United States: authorised in 2018 for smallpox and in 2022 in the European Union for smallpox, mpox and cowpox. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It acts as a 'molecular glue': it makes two copies of the viral protein VP37 pair up, stopping the virus from wrapping itself in the envelope it needs to leave the infected cell.
Go to the active ingredient →Active ingredientTecovirimatCat. No. P-T030-001CAS 869572-92-9
Isotopically labelledTecovirimat-d4Cat. No. P-T030-002CAS 2923753-84-6
ImpurityTecovirimat Impurity 1Cat. No. P-T030-003CAS 68422-98-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.